Jean Koff, MD, MSc, of the Winship Cancer Institute at Emory University School of Medicine, discusses a study presented at the 2022 American Society of Hematology Meeting on the genomic characterization of mantle cell lymphoma.
Jean Koff, MD, MSc, Discusses Genomic Characterization of Mantle Cell Lymphoma
By Cecilia Brown, Jean Koff, MD, MSc - Last Updated: February 1, 2023Post Tags:ASH22
Related Posts
In a narrative review Dr. Krina Patel participated in and describes in this interview, myeloma experts engaged this question.
Dr. Ryan Jacobs reviews the latest CLL data, highlighting time-limited regimens, BTK combos, and clinical trial updates.
Side effects are an important consideration when using bispecific antibodies in this population, Dr. Krina Patel explains.
The phase 3 SENTRY trial will randomize patients to ruxolitinib plus placebo or selinexor plus placebo.
Dr. Krina Patel was part of a comparative study team which evaluated these two therapies' efficacy and safety in MM care.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.